SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-21-014208
Filing Date
2021-11-12
Accepted
2021-11-12 16:36:28
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rebusholdings_10q.htm   iXBRL 10-Q 1104562
2 EXHIBIT 3.16(II) rebusholdings_ex3-16ii.htm EX-3.16(II) 163327
3 EXHIBIT 31.1 rebusholdings_ex31-1.htm EX-31.1 7572
4 EXHIBIT 31.2 rebusholdings_ex31-2.htm EX-31.2 7806
5 EXHIBIT 32.1 rebusholdings_ex32-1.htm EX-32.1 5307
6 EXHIBIT 32.2 rebusholdings_ex32-2.htm EX-32.2 5139
  Complete submission text file 0001829126-21-014208.txt   4334255

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE nspx-20210930.xsd EX-101.SCH 29698
8 XBRL CALCULATION FILE nspx-20210930_cal.xml EX-101.CAL 32375
9 XBRL DEFINITION FILE nspx-20210930_def.xml EX-101.DEF 106983
10 XBRL LABEL FILE nspx-20210930_lab.xml EX-101.LAB 217167
11 XBRL PRESENTATION FILE nspx-20210930_pre.xml EX-101.PRE 177292
12 EXTRACTED XBRL INSTANCE DOCUMENT rebusholdings_10q_htm.xml XML 590497
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Rebus Holdings, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 211404198
SIC: 2834 Pharmaceutical Preparations